New Haven, CT – March 15, 2017: The cognitive science company, Cogstate Ltd (ASX.CGS) announced today that Richard Gleeson has joined the senior leadership team as Chief Technology Officer, strengthening the company’s ability to deliver transformative innovations to optimize the measurement of cognition in clinical trials and healthcare.
Reporting directly to Cogstate Chief Operating Officer, George Hunnewell, Gleeson will lead the company’s global technology organization. He will drive the strategic direction and implementation of technology initiatives to deliver value to Cogstate customers who are seeking higher quality measures for cognitive and other neuropsychological and functional assessments.
“We are in an exciting time where customer needs for digital brain health technologies are rapidly expanding, so we are thrilled that Richard brings 20 years of proven experience in building and deploying high-impact innovations for the collection, analysis, management and integration of clinical data,” commented Hunnewell.
“The thing that has always excited me about technology is its role in improving processes that ultimately bring the right medicines to the right patients,” Gleeson said. “I am very optimistic about where Cogstate is headed and how we can continue to use technology to solve some of the most important challenges in the assessment of brain health.”
Gleeson joins Cogstate from PAREXEL Informatics where he served as Vice President, Global Solution Delivery and was responsible for the pre-sales, deployment and operations of their Clinical Trial Management, Electronic Data Capture, MyTrials Portal, and Analytics and Integration Platform. Previously, he was Vice President at Doctor Evidence, a Health Economics and Outcomes Research company and served as Senior Business Strategy Consultant at Microsoft, working with large enterprise customers and top 25 life science companies. Gleeson earned a BA in Physics from Cal Poly and an MBA from Temple University’s Fox School of Business.